IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma
The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2015 by Radiation Therapy Oncology Group.
Recruitment status was: Active, not recruiting
Recruitment status was: Active, not recruiting
Sponsor:
Radiation Therapy Oncology Group
Collaborators:
National Cancer Institute (NCI)
NRG Oncology
Information provided by (Responsible Party):
Radiation Therapy Oncology Group
ClinicalTrials.gov Identifier:
NCT01026493
First received: December 3, 2009
Last updated: May 8, 2015
Last verified: May 2015
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Study Completion Date: | No date given |
| Primary Completion Date: | May 2014 (Final data collection date for primary outcome measure) |